QFITLIA Trademark

Trademark Overview

On Monday, July 19, 2021, a trademark application was filed for QFITLIA with the United States Patent and Trademark Office. The USPTO has given the QFITLIA trademark a serial number of 90836577. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, October 23, 2024. This trademark is owned by Genzyme Corporation. The QFITLIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hemophilia
qfitlia

General Information

Serial Number90836577
Word MarkQFITLIA
Filing DateMonday, July 19, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, October 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hemophilia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, July 22, 2021NEW APPLICATION ENTERED
Tuesday, July 27, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, September 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 4, 2021ASSIGNED TO LIE
Monday, October 4, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, March 7, 2022ASSIGNED TO EXAMINER
Tuesday, March 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 8, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 8, 2022SOU EXTENSION 1 FILED
Tuesday, November 8, 2022SOU EXTENSION 1 GRANTED
Thursday, November 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 8, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 8, 2023SOU EXTENSION 2 FILED
Monday, May 8, 2023SOU EXTENSION 2 GRANTED
Wednesday, May 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU EXTENSION 3 FILED
Monday, October 23, 2023SOU EXTENSION 3 GRANTED
Wednesday, October 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 3, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 3, 2024SOU EXTENSION 4 FILED
Friday, May 3, 2024SOU EXTENSION 4 GRANTED
Saturday, May 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2024SOU EXTENSION 5 GRANTED
Wednesday, October 23, 2024SOU EXTENSION 5 FILED

Related Keywords

qfitlia hemophilia treatment preparations pharmaceutical